Linear accelerator–based stereotactic arrhythmia radioablation for paroxysmal atrial fibrillation in elderly patients: results from long-term follow-up

Frontiers in Cardiovascular Medicine 2026 Open access

Read full text
Authors: Antonio Di Monaco, Imma Romanazzi, Ilaria Bonaparte, Alessia Surgo, Alba Fiorentino, Massimo Grimaldi
DOI: 10.3389/fcvm.2026.1881828
Cited by: 1
References: 7

Abstract

Stereotactic arrhythmia radioablation (STAR) is an innovative therapeutic approach for cardiac arrhythmias, particularly ventricular tachycardia. Regarding atrial fibrillation (AF), the only study evaluating the safety and feasibility of STAR (photon linear accelerator-based) in elderly patients was published in 2,023. In this brief communication, we reported the long-term follow-up of the enrolled patients. The current data demonstrate the feasibility of STAR in elderly patients with paroxysmal AF and its potential to improve quality of life. The treatment remains experimental, and more comprehensive safety data are necessary; furthermore, its efficacy will require further evaluation in a comparative study vs. catheter ablation.

Fields of Study & Subjects

Cardiac Arrhythmias and Treatments Atrial Fibrillation Management and Outcomes Cardiac pacing and defibrillation studies

Publication details

Journal / source
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Volume
13
Pages
1881828–1881828
Publication date
20 July 2026
Language
EN